MetLife Investment Management’s NCR Atleos NATL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Sell
40,158
-1,472
-4% -$60.8K 0.01% 1124
2025
Q4
$1.59M Sell
41,630
-1,946
-4% -$73K 0.01% 1194
2025
Q3
$1.71M Hold
43,576
0.01% 1162
2025
Q2
$1.24M Hold
43,576
0.01% 1201
2025
Q1
$1.15M Sell
43,576
-707
-2% -$21K 0.01% 1287
2024
Q4
$1.5M Buy
44,283
+2,417
+6% +$73.3K 0.01% 1208
2024
Q3
$1.19M Buy
41,866
+23,590
+129% +$686K 0.01% 1296
2024
Q2
$494K Buy
18,276
+17,018
+1,353% +$415K ﹤0.01% 1721
2024
Q1
$24.8K Buy
1,258
+3
+0.2% +$64 ﹤0.01% 2761
2023
Q4
$30.5K Buy
+1,255
New +$28.7K ﹤0.01% 2797

Other funds holding NATL

MetLife Investment Management's NATL Position: Q1 2026 in Review

MetLife Investment Management reduced its NCR Atleos (NATL) stake by 3.5% in Q1 2026, selling an estimated $60.8K and leaving 40,158 shares worth $1.75M. The position accounts for 0.01% of the portfolio, ranked #1124.

MetLife Investment Management first reported a position in NATL in Q4 2023 and has held it in 10 quarters since. 363 funds tracked by Wall St. Rank hold NATL as of Q1 2026.

  • MetLife Investment Management held 40,158 shares of NCR Atleos worth $1.75M as of Q1 2026.
  • MetLife Investment Management sold 1,472 NCR Atleos shares in Q1 2026, an estimated $60.8K.
  • NCR Atleos made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1124 holding.
  • MetLife Investment Management first reported a position in NCR Atleos in Q4 2023 and has held it in 10 quarters since.
  • 363 funds tracked by Wall St. Rank held NCR Atleos as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.